ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dietary Phosphorus, Its Sources, and Mortality in Adults on Haemodialysis: The DIET-HD Study

Su, Guobin; Saglimbene, Valeria; Wong, Germaine; Bernier-Jean, Amelie; Carrero, Juan Jesus; Natale, Patrizia; Ruospo, Marinella; Hegbrant, Jorgen; Craig, Jonathan C.; Strippoli, Giovanni F. M.*广东省人民医院; 广州中医药大学; i
OncoImmunology2022-10DOI: 10.3390/nu14194064
2被引13阅读
引用收藏
分享

摘要

Dietary phosphorus restrictions are usually recommended for people on haemodialysis, although its impact on patient-relevant outcomes is uncertain. We aimed to evaluate the association between total phosphorus intake and its sources with mortality in haemodialysis. Phosphorus intake was ascertained within the DIET-HD study in 8110 adults on haemodialysis. Adjusted Cox regression analyses were conducted to evaluate the association between the total and source-specific phosphorus (plant-, animal-, or processed and other sources) with mortality. During a median 3.8 years of follow-up, there were 2953 deaths, 1160 cardiovascular-related. The median phosphorus intake was 1388 mg/day. Every standard deviation (SD) (896 mg/day) increase in total phosphorus was associated with higher all-cause mortality [hazard ratio (HR), 1.16; 95% confidence intervals (CI), 1.06-1.26] and cardiovascular mortality (HR, 1.18; 95% CI, 1.03-1.36). Every SD (17%) increase in the proportion of phosphorus from plant sources was associated with lower all-cause mortality (HR, 0.95; 95% CI, 0.90-0.99). Every SD (9%) increase in the proportion of phosphorus from the processed and other sources was associated with higher all-cause mortality (HR, 1.06; 95% CI, 1.02-1.10). A higher total phosphorus intake was associated with increased all-cause and cardiovascular death. This association is driven largely by the phosphorus intake from processed food. Plant based phosphorus was associated with lower all-cause mortality.

学科与关键词

关键词
phosphorusplant-basemortalityhaemodialysiscohortDIET-HD
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
OncoImmunology
发表日期
2022-10
卷期
第 14 卷, 第 19 期
页码
4064
DOI
10.3390/nu14194064
语言
ENGLISH
期刊收录
SCIE
期刊等级
2区
成果收录
SCIE
资助标注
National Nature Science Foundation of China, China [82004205]; Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine [BJ2022KY11]; Science and Technology Research Fund from Guangdong Provincial Hospital of Chinese Medicine, China [YN2018QL08]; Karolinska Institutet research funds, Sweden [2020-01616]; European Renal Association (ERA); Swedish Research Council [2019-01059]; Formas [2020-01616] Funding Source: Formas

作者

  • S

    Su, Guobin (第一作者)

    i · 2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Saglimbene, Valeria

    i

查看全部 10 位作者收起作者
  • W

    Wong, Germaine

  • B

    Bernier-Jean, Amelie

  • C

    Carrero, Juan Jesus

    i

  • N

    Natale, Patrizia

    i

  • R

    Ruospo, Marinella

    i

  • H

    Hegbrant, Jorgen

  • C

    Craig, Jonathan C.

  • S

    Strippoli, Giovanni F. M. (通讯)

    i

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417